Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals LtdfiledCriticalGlenmark Pharmaceuticals Ltd
Priority to MX2013003022ApriorityCriticalpatent/MX366763B/es
Publication of MX2013003022ApublicationCriticalpatent/MX2013003022A/es
Publication of MX366763BpublicationCriticalpatent/MX366763B/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La solicitud de patente se refiere a las composiciones farmacéuticas de dosis fijas para administración oral que comprende montelukast o sus sales y levocetirizina o sus sales.
MX2013003022A2013-03-152013-03-15Composiciones farmacéuticas de montelukast y levocetirizina.
MX366763B
(es)